Arrowhead Pharmaceuticals (ARWR) Other Non-Current Liabilities (2011 - 2026)
Arrowhead Pharmaceuticals' Other Non-Current Liabilities came in at $392.51 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 9.0% from $360.25 million a year earlier and up 2.3% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Other Non-Current Liabilities was $367.4 million, up 7.6% from FY2024.
- Going back by fiscal year, Other Non-Current Liabilities was $341.36 million in FY2024 (+27.2%) and $268.33 million in FY2023.
- The fiscal Q3 2026 figure represents the highest quarterly Other Non-Current Liabilities in data going back to fiscal Q4 2011.
- Year-over-year, Other Non-Current Liabilities has increased for 11 consecutive quarters, with growth averaging 15.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Other Non-Current Liabilities ranged from 7.2% (fiscal Q3 2025) to 27.7% (fiscal Q3 2024).
- Business Quant data shows ARWR's Other Non-Current Liabilities at $383.83 million (Q2 2026), $375 million (Q1 2026) and $367.4 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 392.51 Mn |
| Mar 31, 2026 | 383.83 Mn |
| Dec 31, 2025 | 375.00 Mn |
| Sep 30, 2025 | 367.40 Mn |
| Jun 30, 2025 | 360.25 Mn |
| Mar 31, 2025 | 352.28 Mn |
| Dec 31, 2024 | 346.78 Mn |
| Sep 30, 2024 | 341.36 Mn |
| Jun 30, 2024 | 336.03 Mn |
| Mar 31, 2024 | 280.94 Mn |
| Dec 31, 2023 | 273.69 Mn |
| Sep 30, 2023 | 268.33 Mn |
| Jun 30, 2023 | 263.06 Mn |
| Mar 31, 2023 | 257.91 Mn |
| Dec 31, 2022 | 252.85 Mn |
| Sep 30, 2019 | 3.70 Mn |
| Jun 30, 2019 | 1.81 Mn |
| Mar 31, 2019 | 1.75 Mn |
| Dec 31, 2018 | 1.66 Mn |
| Sep 30, 2018 | 1.70 Mn |
API Access
Arrowhead Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();